Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic network failures in Alzheimer's disease: A biochemical road map
Jon B. Toledo, Matthias Arnold, Gabi Kastenmüller, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 9, pp. 965-984
Open Access | Times Cited: 419

Showing 1-25 of 419 citing articles:

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
Erik C. B. Johnson, Eric B. Dammer, Duc M. Duong, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 769-780
Open Access | Times Cited: 759
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma, Anup Mammen Oommen, Sudhir Varma, et al.
PLoS Medicine (2018) Vol. 15, Iss. 1, pp. e1002482-e1002482
Open Access | Times Cited: 417
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Dallas P. Veitch, Michael W. Weiner, Paul Aisen, et al.
Alzheimer s & Dementia (2018) Vol. 15, Iss. 1, pp. 106-152
Closed Access | Times Cited: 394
Skyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics
Kendra J. Adams, Brian Pratt, Neelanjan Bose, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 4, pp. 1447-1458
Open Access | Times Cited: 392
Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities
Judit Perez Ortiz, Russell H. Swerdlow
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3489-3507
Open Access | Times Cited: 360
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
Kwangsik Nho, Alexandra Kueider‐Paisley, Siamak MahmoudianDehkordi, et al.
Alzheimer s & Dementia (2018) Vol. 15, Iss. 2, pp. 232-244
Open Access | Times Cited: 269
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Maija Dambrova, Marina Makrecka-Kūka, Janis Kuka, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 506-551
Open Access | Times Cited: 265
Association of branched‐chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts
Juho Tynkkynen, Vincent Chouraki, Sven J. van der Lee, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 6, pp. 723-733
Open Access | Times Cited: 225
Application of Metabolomics in Alzheimer’s Disease
Jordan Wilkins, Eugenia Trushina
Frontiers in Neurology (2018) Vol. 8
Open Access | Times Cited: 223
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
Vera van der Velpen, Tony Teav, Héctor Gallart‐Ayala, et al.
Alzheimer s Research & Therapy (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 208
Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression
Raoxu Wang, Bowen Li, Sin Man Lam, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2019) Vol. 47, Iss. 2, pp. 69-83
Closed Access | Times Cited: 208
Multi-omics integration in biomedical research – A metabolomics-centric review
Maria A. Wörheide, Jan Krumsiek, Gabi Kastenmüller, et al.
Analytica Chimica Acta (2020) Vol. 1141, pp. 144-162
Open Access | Times Cited: 197
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
Kwangsik Nho, Alexandra Kueider‐Paisley, Shahzad Ahmad, et al.
JAMA Network Open (2019) Vol. 2, Iss. 7, pp. e197978-e197978
Open Access | Times Cited: 184
Guide to Metabolomics Analysis: A Bioinformatics Workflow
Yang Chen, En‐Min Li, Li‐Yan Xu
Metabolites (2022) Vol. 12, Iss. 4, pp. 357-357
Open Access | Times Cited: 171
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 160
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
Matthias Arnold, Kwangsik Nho, Alexandra Kueider‐Paisley, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 154
Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle
Jens V. Andersen, Arne Schousboe, Alexei Verkhratsky
Progress in Neurobiology (2022) Vol. 217, pp. 102331-102331
Closed Access | Times Cited: 149
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Xiaohang Qian, Xiaoxuan Song, Xiaoli Liu, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101317-101317
Closed Access | Times Cited: 119
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Harald Hampel, Robert Nisticò, Nicholas T. Seyfried, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101346-101346
Closed Access | Times Cited: 107
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
Emrin Horgusluoglu, Ryan Neff, Won‐Min Song, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 6, pp. 1260-1278
Open Access | Times Cited: 106
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
Aikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4022-4022
Open Access | Times Cited: 99
The metabolomics of human aging: Advances, challenges, and opportunities
Daniel J. Panyard, Bing Yu, M Snyder
Science Advances (2022) Vol. 8, Iss. 42
Open Access | Times Cited: 91
Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
Amaia Ezkurdia, Marı́a J. Ramı́rez, Maite Solas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4354-4354
Open Access | Times Cited: 72
Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective
Lance M. O’Connor, Blake A. O’Connor, Su Bin Lim, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 8, pp. 836-850
Open Access | Times Cited: 48
Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yuluğ, Özlem Altay, Xiangyu Li, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top